bioAffinity Technologies, Inc.
Diagnostics & Research
Healthcare
BIAF
801 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.11
52 week high
5.17
high
5.30
52 week low
0.00
low
4.80
growth
-2.21 %
previous Close
5.17
P/E ratio
market cap
4.91 M
div yield
0
usd
Jun 2025
qoq
revenue
1.27 M
-31.53 %
net incoming
-4.06 M
-52.66 %
eps
0.00 %
10.76 %
eps surprise
-70.00 %
net profit margin
-319.88 %
-176.00 %
operating incoming
-2.52 M
4.24 %
net change in cash
358 K
154.21 %
cash on hand
803 K
80.53 %
cost of revenue
1.02 M
-25.69 %
top top